TDOC Stock Recent News
TDOC LATEST HEADLINES
While the top- and bottom-line numbers for Teladoc (TDOC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Teladoc (TDOC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.17 per share a year ago.
Teladoc Health (TDOC -1.70%), a leader in telehealth services, released its fourth-quarter earnings on Feb. 26. The company reported revenue of $640.5 million, just above the $639 million that analysts had expected, but 3% lower than the same quarter last year.
Teladoc Health shares fell in extended trading on Wednesday after the company issued weak guidance and reported a bigger loss than expected. Revenue at the telehealth company decreased 3% in the fourth quarter to $640.5 million.
PURCHASE, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December 31, 2024 (“Full Year 2024”) and three months ended December 31, 2024 (“Fourth Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the full year ended December 31, 2023 (“Full Year 2023”) and three months ended December 31, 2023 (“Fourth Quarter 2023”).
PURCHASE, NY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the TD Cowen 45th Annual Health Care Conference in Boston on Monday, March 3rd, 2025, at 10:30 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations .
NEW YORK CITY, NY / ACCESS Newswire / February 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEWTOWN, Pa. , Feb. 21, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Teladoc Health Inc. (NYSE: TDOC) resulting from allegations of providing potentially misleading business information to the investing public.
Evaluate the expected performance of Teladoc (TDOC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
BOSTON, MA / ACCESS Newswire / February 21, 2025 / Block & Leviton is investigating Teladoc Health, Inc. (NYSE:TDOC) for potential securities law violations. Investors who have lost money in their Teladoc Health, Inc. investment should contact the firm to learn more about how they might recover those losses.